The objective of this study is to understand the molecular basis of Leber's Hereditary Optic Neuropathy (LHON), a maternally inherited disease of young adults which features rapid and painless bilateral loss of central vision due to optic nerve atrophy. LHON results from missense mutations in the mitochondrial DNA (mtDNA) and is genetically heterogeneous as 16 different mtDNA mutations have been associated with the diseases. Five mutations are considered high risk (primary) etiological factors and together account for roughly 805 of all LHON patients in the US and Europe. All high-risk LHON mutations are found in mtDNA encoded subunits of respiratory Complex I (NADH) dehydrogenase), suggestive of a common biochemical defect. However, very little is known about the functional consequences of these mutations, thus the underlying molecular mechanism(s) of this bioenergetic disease remains unsolved which, in turn, has prevented the development of any form of efficacious therapy. To determine the nature of the Complex I defect in LHON patients, two sets of experiments are proposed. First, oxidative phosphorylation biochemical defects will be investigated in patient and control lymphoblastoid cell lines. Both polarographic and spectrophotometric techniques will be used to assay mitochondrial respiration and respiratory enzyme specific activity, respectively. Patient groups to be studied include those harboring only a primary mutation, those harboring only secondary mutations, and those containing both primary and secondary LHON mutations. Second, Paracoccus denitrificans and Escherichia coli will be used as model organisms to study the consequences of the LHON Complex I mutations on enzyme structure and function. Amino acids altered by LHON mutations are conserved in these well- characterized bacteria, in which genetic manipulations are straightforward. P. denitrificans contains a NADH dehydrogenase which is remarkably similar to its mammalian counterpart and E. coli represents a """"""""minimal"""""""" proton- translocating NADH dehydrogenase. Primary Complex I LHON mutations will be transferred to the bacteria and mutant bacteria will be assayed for: 1) in vivo aerobic phenotype, 2) specific activity of NADH dehydrogenase, 3) number and function of the critical NADH dehydrogenase Fe-S redox clusters, and 4) structural integrity and stoichiometry of the enzyme complex and its constituent subunits. Completion of this study should result in an understanding of the molecular basis of LHON which will in turn permit the design of effective therapies for this and other bioenergetic diseases.

Agency
National Institute of Health (NIH)
Institute
National Eye Institute (NEI)
Type
First Independent Research Support & Transition (FIRST) Awards (R29)
Project #
5R29EY011305-02
Application #
2020028
Study Section
Visual Sciences A Study Section (VISA)
Project Start
1995-12-07
Project End
2000-11-30
Budget Start
1996-12-01
Budget End
1997-11-30
Support Year
2
Fiscal Year
1997
Total Cost
Indirect Cost
Name
Emory University
Department
Genetics
Type
Schools of Medicine
DUNS #
042250712
City
Atlanta
State
GA
Country
United States
Zip Code
30322
Brown, Michael D; Starikovskaya, Elena; Derbeneva, Olga et al. (2002) The role of mtDNA background in disease expression: a new primary LHON mutation associated with Western Eurasian haplogroup J. Hum Genet 110:130-8
Brown, M D; Allen, J C; Van Stavern, G P et al. (2001) Clinical, genetic, and biochemical characterization of a Leber hereditary optic neuropathy family containing both the 11778 and 14484 primary mutations. Am J Med Genet 104:331-8
Brown, M D; Zhadanov, S; Allen, J C et al. (2001) Novel mtDNA mutations and oxidative phosphorylation dysfunction in Russian LHON families. Hum Genet 109:33-9
Brown, M D; Trounce, I A; Jun, A S et al. (2000) Functional analysis of lymphoblast and cybrid mitochondria containing the 3460, 11778, or 14484 Leber's hereditary optic neuropathy mitochondrial DNA mutation. J Biol Chem 275:39831-6
Brown, M D (1999) The enigmatic relationship between mitochondrial dysfunction and Leber's hereditary optic neuropathy. J Neurol Sci 165:1-5
Biousse, V; Brown, M D; Newman, N J et al. (1997) De novo 14484 mitochondrial DNA mutation in monozygotic twins discordant for Leber's hereditary optic neuropathy. Neurology 49:1136-8
Brown, M D; Sun, F; Wallace, D C (1997) Clustering of Caucasian Leber hereditary optic neuropathy patients containing the 11778 or 14484 mutations on an mtDNA lineage. Am J Hum Genet 60:381-7
Muth, J; Williams, P M; Williams, S J et al. (1996) Fast capillary electrophoresis-laser induced fluorescence analysis of ligase chain reaction products: human mitochondrial DNA point mutations causing Leber's hereditary optic neuropathy. Electrophoresis 17:1875-83